Tag: generic drug entry
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV under the Hatch-Waxman Act lets generic drug makers challenge brand patents to speed up affordable drug access. It’s how most generic drugs enter the market-and why prices drop so sharply.
Read more